Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odyliresin in Symptomatic Benign Prostatic Hyperplasia
NCT02977832Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by IRCCS San Matteo Foundation. Primary endpoint: International Prostate Symptom Score at 12 months. Started Jan 2015; status: completed.
Beyond the preview
Go deeper on NCT02977832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02977832.